Kai Yamasaki

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 257 citations · Full text

TERT promoter mutation status is necessary and sufficient to diagnose IDH-wildtype diffuse astrocytic glioma with molecular features of glioblastoma

Kenji Fujimoto, Hideyuki Arita, Kaishi Satomi et al. · Acta Neuropathologica · 2021 · 103 citations

Neuro-oncology, Somatic Variant, Medicine +9

Genome-wide methylation profiles in primary intracranial germ cell tumors indicate a primordial germ cell origin for germinomas

Shintaro Fukushima, Satoshi Yamashita, Hisato Kobayashi et al. · Acta Neuropathologica · 2017 · 92 citations

Developmental Biology, Germ Cell, Somatic Variant +9

TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations

Hideyuki Arita, Yuko Matsushita, Ryunosuke Machida et al. · Acta Neuropathologica Communications · 2020 · 72 citations · Full text

The Japan Society for Neuro-Oncology guideline on the diagnosis and treatment of central nervous system germ cell tumors

Hideo Nakamura, Hirokazu Takami, Takaaki Yanagisawa et al. · Neuro-Oncology · 2021 · 69 citations · Full text

Surgical Oncology, Tumor Innervation, Cns Gcts +18